GLP-1s in the Wild @ JPM 2026
Join Evidation for a panel discussion and hosted reception at JPM 2026.
GLP-1s in the Wild is an interactive salon at the intersection of science, behavior, and culture—exploring how incretin-based therapies are reshaping daily life in the real world. This session brings together executives and innovators with firsthand experience to share data, stories, and insights about the use of GLP-1s in the real world.
Featured Speakers:
Geoff Cook, CEO, Noom
Jamie Coleman, Chief Commercial Officer, Kailera Therapeutics
Lindsey Holden, Co-founder, COO, Baseline Therapeutics & Center for Addiction Science, Policy, & Research
Rachel Sha, CEO, Vaxess Technologies
Please note: this event is by invitation. For questions or to request an invite, please email [email protected].
